Comparison
1p35 2 Microdeletion Syndrome vs 12q14 Microdeletion Syndrome C4305140
Clinical comparison between 1p35 2 Microdeletion Syndrome and 12q14 Microdeletion Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
1p35 2 Microdeletion Syndrome
0-null
12q14 Microdeletion Syndrome C4305140
0-2
Onset patterns differ
Severity
1p35 2 Microdeletion Syndrome
severe
12q14 Microdeletion Syndrome C4305140
moderate
Different severity levels
Chronic
1p35 2 Microdeletion Syndrome
Chronic
12q14 Microdeletion Syndrome C4305140
Chronic
Differing course
Communicable
1p35 2 Microdeletion Syndrome
No
12q14 Microdeletion Syndrome C4305140
No
Different transmission
Body System
1p35 2 Microdeletion Syndrome
congenital
12q14 Microdeletion Syndrome C4305140
congenital
Same/different system
Category
1p35 2 Microdeletion Syndrome
rare-disease
12q14 Microdeletion Syndrome C4305140
genetic
Different category
Bottom line
1p35-2-microdeletion-syndrome-C5679992 and 12q14-microdeletion-syndrome-C4305140 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1p35 2 Microdeletion Syndrome | 12q14 Microdeletion Syndrome C4305140 | Discriminating power |
|---|---|---|---|
| Developmental delay | Not established from supplied data; do not assume a specific pattern. | May include developmental delay and learning difficulty. | Low |
| Overall clinical severity | Axis data label severity as severe, but features are unspecified. | Described as moderate, with variable health issues. | Moderate |
| Age at recognition | Onset coded 0-null; timing is not clearly established. | Onset coded from birth to about 2 years. | Moderate |
When to favor each condition
Choose 1p35 2 Microdeletion Syndrome when
A deletion is mapped to 1p35.2
The chromosomal locus, not symptoms alone, defines this entity.
High
Phenotype is severe but nonspecific
Severity labeling does not prove the diagnosis without genetics.
Low
Family counseling after confirmed testing
Counseling should follow the laboratory-reported locus and size.
High
Choose 12q14 Microdeletion Syndrome C4305140 when
A deletion is mapped to 12q14
Locus confirmation distinguishes it from other microdeletions.
High
Early developmental or learning concerns
These are described possible features, not diagnostic alone.
Moderate
Supportive care planning
Management is individualized and focuses on supportive therapies.
Moderate
How key tests differ
| Test | 1p35 2 Microdeletion Syndrome | 12q14 Microdeletion Syndrome C4305140 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss involving 1p35.2 if present. | Copy-number loss involving 12q14 if present. | The reported locus is the main discriminator; clinician review is needed. |
| Karyotype or FISH | May miss a small deletion; targeted testing depends on suspicion. | Likewise may miss a small deletion unless targeted. | A normal result does not exclude either condition. |
| Clinical examination | No definitive symptom pattern is established here. | May show developmental or learning concerns and other issues. | Examination supports evaluation but cannot replace genetic testing. |
Prognosis comparison
1p35 2 Microdeletion Syndrome
- Outcome
- Long-term outcome is not established from the supplied data.
- Factors
- Reported severity is severe, but specific predictors are unavailable.
12q14 Microdeletion Syndrome C4305140
- Outcome
- Often managed supportively; outcome varies and is not precisely defined here.
- Factors
- Developmental, learning, and other health issues may influence needs.
Time frame: Lifelong congenital conditions; exact course is not established.
Deletion locus, size, associated findings, and access to support may matter.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental and learning needs | Possible but not specified in the source. Developmental delay and learning difficulty are described. Needs assessment should be individualized. |
| Other health issues | Not established; avoid assuming organ involvement. Other health issues may occur, without a fixed list here. Surveillance should follow clinician judgment. |
| Diagnostic uncertainty | Sparse source data increase uncertainty. Better described, but still variable. Neither label should be assigned from symptoms alone. |
Patient education highlights
- HighDiagnosis
Only genetic testing that identifies the chromosome segment can distinguish these conditions.
- HighCare
Care is supportive and individualized; no dose or specific treatment is established here.
- MediumExpectations
Features and outlook vary. Ask a genetics clinician before making prognostic conclusions.